Advertisement for orthosearch.org.uk
Results 1 - 4 of 4
Results per page:
Applied filters
General Orthopaedics

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXI | Pages 39 - 39
1 May 2012
K. D S. A D. K
Full Access

Aim

Up to 34% of fractures of the distal radius in children can ‘re-displace’ early after reduction. Main risk factors are initial displacement (bayonet apposition, > 50% translation, and > 30°angulation), isolated distal radius fracture, associated ulna fracture at the same level, inadequate initial closed reduction and poor casting technique. This study was to identify the rate of ‘re-displacement’ following first successful reduction in distal radius fractures. We also assessed the risk factors associated with initial injury and compared the efficacy of the available indices to assess the quality of casting.

Materials & Methods

We performed a case note based radiographic analysis of 90 distal radius fractures treated at our centre from 2005 to 2008. A cohort of 18 patients with re-displacement was compared with 72 patients with maintenance of reduction. Radiological indices were calculated to assess the quality of casting technique. The patient and fracture demographics were compared between the two groups. Statistical analysis was carried out using ANOVA, Fisher's Exact Test and multiple logistic regression analysis.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXI | Pages 180 - 180
1 May 2012
R. G C. C S. C R. T S. A L. J
Full Access

Background

Advances in diagnosis and treatment should mean that hindquarter amputation is now rarely needed. Unfortunately this is not the case. We have performed 166 of these amputations in the past 36 years. We have investigated the reasons why this procedure is still required and the outcomes following it.

Method

A retrospective review of data stored on a prospective database.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXI | Pages 21 - 21
1 May 2012
M. S S. A F.S. H J. M
Full Access

Background and aim

Total hip replacements (THRs) are associated with significant blood loss which often requires high transfusion rates of allogeneic blood. Although safer than ever, allogeneic blood transfusion is still associated with risks to the recipients. This meta-analysis aims to investigate the efficacy and safety of tranexamic acid (TXA) in reducing blood loss and allogeneic blood transfusion after THR.

Patients and Methods

A systematic review and meta-analysis of published randomised controlled trials which used TXA to reduce blood loss and transfusion in hip arthroplasty were conducted. The data were evaluated using the generic evaluation tool designed by the Cochrane Bone, Joint and Muscle Trauma Group.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXI | Pages 177 - 177
1 May 2012
R. G S. C R. T S. A L J
Full Access

Since 1970, 2200 primary endoprosthetic replacements have been carried out at our Unit for bone tumours. 3% were carried out in the 1970s, 21% in the 1980s, 33% in the 1990s and 43% since 2000.

The most common diagnosis was osteosarcoma (839)(38%) followed by metastatic disease (18%) and chondrosarcoma (13%). The most common site was the distal femur (35%) followed by the proximal femur and proximal tibia. The least common sites were the scapula and distal radius. The mean age at operation was 35 but varied widely, being 19 in patients with osteosarcoma and 58 for those with metastases. 239 extendable prostheses were inserted in children. 50% of the patients were alive at 10yrs and 42% at 20yrs. 7% required an amputation either for local recurrence or infection.

The failure rate of the prostheses varied by age and site, with pelvic and proximal tibial replacements having the highest risk of infection and proximal humeral replacements the lowest risk of any complication. The failure rates of the most common prostheses (distal femur and proximal tibia) have improved over time and are now ~ 1.5% per year. Hydroxyapatite collars have largely resolved the problem of aseptic loosening. Silver coated prostheses have been used in 48 complex cases with encouraging results in controlling infection. Functional scores averaged 80% and were the same for revision as for primary implants.

Conclusion

Significant improvements of design have improved endoprosthetic replacements for tumours. Results are now fairly predictable but still not as good as primary joint replacemenrts. Infection remains the most serious challenge.